RVMD
RVMD
US76155X1000
Revolution Medicines, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
40.67B EUR
40.12B EUR
19.47B EUR
15.69B EUR
Enterprise Value
37.57B EUR
39.95B EUR
19.18B EUR
15.47B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-32.55x
--
--
--
Price to Sales
--
--
--
--
Price to Book
15.6x
15.4x
12.98x
9.62x
EV/Revenue
--
--
--
--
EV/EBITDA
-23.22x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.75%
-3.96%
-5.51%
-4.56%
ende